Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000551043 | SCV000629241 | benign | Pityriasis rubra pilaris; Psoriasis 2 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002263751 | SCV002543266 | benign | Autoinflammatory syndrome | 2022-03-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000551043 | SCV002807558 | likely benign | Pityriasis rubra pilaris; Psoriasis 2 | 2021-09-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925594 | SCV004739042 | benign | CARD14-related disorder | 2019-04-01 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |